daunorubicin has been researched along with deoxycholic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
Cuilleron, CY; de Ravel, MR; Dumontet, C; Grenot, C; Matera, EL; Monniot, E; Radix, S; Rocheblave, L; Tavenard, J; Walchshofer, N | 1 |
2 other study(ies) available for daunorubicin and deoxycholic acid
Article | Year |
---|---|
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
Deoxycholic acid derivatives as inhibitors of P-glycoprotein-mediated multidrug efflux.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Deoxycholic Acid; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells | 2016 |